Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links
Cat.#: ACPP-1246
| Despition | Bestrophin Blocking Peptide for Immunodepletion, Immunocompetition |
| SIZE | 250 µg |
| Applications | Immunodepletion & Immunocompetition assay |
| Storage | Store at -20⁰C for long term |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ACPP-1494 | beta Catenin Blocking Peptide (AC1494) | 250 µg | inquiry |
| ACPP-1371 | Ki67 Blocking Peptide (AC1371) | 250 µg | inquiry |
| ACPP-1528 | Human RCAN3 Protein (AC1528) | 2 µg | inquiry |
| ACPP-1326 | Galectin 3 Blocking Peptide (AC1326) | 250 µg | inquiry |
| ACPP-1804 | Human STMN2 Protein (AC1804) | 2 µg | inquiry |
| ACPP-1204 | P2Y1 Blocking Peptide (AC1204) | 250 µg | inquiry |
| ACPP-1348 | Presenilin 1 Blocking Peptide (AC1348) | 250 µg | inquiry |
| ACPP-1454 | Human PICK1 Protein (AC1454) | 2 µg | inquiry |
| ACPP-1200 | PAX8 Blocking Peptide (AC1200) | 250 µg | inquiry |
| ACPP-1035 | Recombinant Mouse TNF Receptor II Protein (6×His Tag) (AC1035) | 50 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.